EBS

9.07

9.66% -0.97

Handel nachbörslich: 9.00 -0.07 -0.77%

Emergent Biosolutions Inc (EBS)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$10.04

Offen:

$9.97

24-Stunden-Volumen:

1.17M

Relative Volume:

1.05

Marktkapitalisierung:

$483.89M

Einnahmen:

$1.02B

Nettoeinkommen (Verlust:

$-757.20M

KGV:

-0.6145

EPS:

-14.76

Netto-Cashflow:

$-257.90M

1W Leistung:

-0.87%

1M Leistung:

+13.80%

6M Leistung:

+112.91%

1J Leistung:

+7.34%

1-Tages-Spanne:

$9.06

$10.02

1-Wochen-Bereich:

$8.85

$10.10

52-Wochen-Spanne:

$4.02

$12.73

Emergent Biosolutions Inc Stock (EBS) Company Profile

Firmenname

Emergent Biosolutions Inc

Sektor

Healthcare (1141)

Branche

Drug Manufacturers - Specialty & Generic (83)

Telefon

240-631-3200

Adresse

300 PROFESSIONAL DR, GAITHERSBURG, MD

Mitarbeiter

900

Twitter

@emergentbiosolu

Nächster Verdiensttermin

2025-03-03

Neueste SEC-Einreichungen

EBS's Discussions on Twitter

Vergleichen Sie EBS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EBS Emergent Biosolutions Inc	9.07	535.65M	1.02B	-757.20M	-257.90M	-14.76
ZTS Zoetis Inc	141.11	63.55B	9.39B	2.62B	2.22B	5.8121
TAK Takeda Pharmaceutical Co Adr	13.71	44.47B	29.96B	957.25M	4.77B	0.2956
HLN Haleon Plc Adr	9.00	40.17B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	20.03	22.99B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	440.00	20.14B	3.08B	1.24B	1.07B	25.61

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-30	Eingeleitet	H.C. Wainwright	Buy
2024-08-22	Eingeleitet	Rodman & Renshaw	Buy
2024-03-07	Hochstufung	The Benchmark Company	Hold → Buy
2023-11-20	Fortgesetzt	JP Morgan	Underweight
2023-08-29	Herabstufung	The Benchmark Company	Buy → Hold
2023-04-10	Hochstufung	The Benchmark Company	Hold → Buy
2023-03-17	Herabstufung	JP Morgan	Neutral → Underweight
2022-11-10	Herabstufung	The Benchmark Company	Buy → Hold
2022-04-29	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2022-01-20	Hochstufung	The Benchmark Company	Hold → Buy
2021-11-08	Herabstufung	The Benchmark Company	Buy → Hold
2021-05-05	Herabstufung	Argus	Buy → Hold
2021-04-07	Eingeleitet	The Benchmark Company	Buy
2021-02-24	Hochstufung	Chardan Capital Markets	Neutral → Buy
2021-02-19	Herabstufung	Chardan Capital Markets	Buy → Neutral
2021-01-08	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-09-14	Fortgesetzt	JP Morgan	Neutral
2020-07-31	Bestätigt	Chardan Capital Markets	Buy
2019-09-12	Eingeleitet	Guggenheim	Buy
2019-09-04	Hochstufung	Wells Fargo	Market Perform → Outperform
2018-11-02	Hochstufung	Goldman	Neutral → Buy
2018-08-03	Bestätigt	Chardan Capital Markets	Buy
2018-06-13	Eingeleitet	Argus	Buy
2018-04-25	Herabstufung	Wells Fargo	Outperform → Market Perform
2018-01-24	Eingeleitet	Goldman	Neutral
2018-01-16	Bestätigt	Chardan Capital Markets	Buy
2016-06-28	Bestätigt	Singular Research	Buy
2016-04-15	Eingeleitet	Chardan Capital Markets	Buy
2016-03-28	Eingeleitet	Singular Research	Buy
2016-02-19	Eingeleitet	Wells Fargo	Outperform
2014-05-15	Eingeleitet	Summer Street Research	Buy
2011-05-31	Bestätigt	WBB Securities	Strong Buy
2011-01-10	Bestätigt	Wedbush	Outperform
2010-11-05	Bestätigt	Wedbush	Outperform
2010-08-18	Hochstufung	WBB Securities	Buy → Strong Buy
2010-08-06	Bestätigt	Caris & Company	Buy

Alle ansehen

Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten

09:50 AM

Short interest data insights for Emergent BioSolutions Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com

09:50 AM

05:46 AM

How strong is Emergent BioSolutions Inc. stock balance sheetJuly 2025 Update & Consistent Profit Alerts - newser.com

05:46 AM

12:55 PM

Emergent Biosolutions (NYSE:EBS) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat

12:55 PM

12:48 PM

Is Emergent BioSolutions Inc. (ER4) stock dividend growth reliableQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

12:48 PM

Oct 08, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) Shares Bounce 31% But Its Business Still Trails The Industry - simplywall.st

Oct 08, 2025

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - The Manila Times

Oct 08, 2025

Emergent BioSolutions Inc. Announces Conference Call for Third Quarter 2025 Financial Results - Quiver Quantitative

Oct 08, 2025

Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Stock Price Up 5.3%Still a Buy? - MarketBeat

Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat

Oct 07, 2025

Oct 06, 2025

Quantitative breakdown of Emergent BioSolutions Inc. recent moveTrade Ideas & Growth Focused Entry Reports - newser.com

Oct 06, 2025

Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendationsWeekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Is Emergent BioSolutions Inc. (ER4) stock a buy during volatile marketsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com

Oct 05, 2025

Published on: 2025-10-05 04:23:16 - newser.com

Oct 05, 2025

Oct 03, 2025

Is Emergent BioSolutions Inc. stock a top pick in earnings season2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Oct 03, 2025

Relative strength of Emergent BioSolutions Inc. in sector analysisWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com

Oct 03, 2025

How to interpret RSI for Emergent BioSolutions Inc. stockPortfolio Update Report & Weekly Setup with ROI Potential - newser.com

Oct 03, 2025

Strategies to average down on Emergent BioSolutions Inc.Portfolio Value Report & AI Powered Market Trend Analysis - newser.com

Oct 03, 2025

Multi factor analysis applied to Emergent BioSolutions Inc.CEO Change & Entry Point Strategy Guides - newser.com

Oct 03, 2025

Sep 28, 2025

Is Emergent BioSolutions Inc. stock poised for growth2025 Stock Rankings & Consistent Profit Alerts - newser.com

Sep 28, 2025

Emergent BioSolutions Inc Stock Analysis and ForecastVolatility Index Analysis & Big Profit Small Budget - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Is Emergent BioSolutions Inc ER4 a good long term investmentMarket Insider Reports & Affordable Investment Strategies - Early Times

Sep 27, 2025